Skip to content

Clinical trials

Neoplasms by Site trials in South Korea

Search ClinicalTrials.gov registrations by keyword, then narrow by condition, phase, status, country and start year.

Filters: Condition: Neoplasms by Site Country / region: South Korea Clear all

31 trials match Source: ClinicalTrials.gov registrations

Trials started per year

By phase, 2000 to 2026.

Trials started per year
CategoryTrials
20091
20101
20142
20151
20163
20174
20195
20201
20214
20223
20232
20251
20263

Status

Trials by registry status. Select a bar to filter.

Trials by status
CategoryTrials
Completed10
Recruiting9
Active, not recruiting6
Terminated6

Top lead sponsors

A sponsor with a page on Pharma Observatory links to it.

Top lead sponsors
CategoryTrials
AstraZeneca4
Eli Lilly and Company3
Hoffmann-La Roche3
Revolution Medicines, Inc.3
Blueprint Medicines Corporation2
Novartis Pharmaceuticals2
Sumitomo Pharma America, Inc.2
AVEO Pharmaceuticals, Inc.1
Abbott1
Astellas Pharma Global Development, Inc.1

Top conditions

MeSH conditions the trials were registered with, not their broader categories. A condition with a page on Pharma Observatory links to it.

Top conditions
CategoryTrials
Neoplasms by Site31
Neoplasms29
Carcinoma, Non-Small-Cell Lung13
Lung Neoplasms13
Lung Diseases12
Neoplasms by Histologic Type12
Respiratory Tract Diseases12
Respiratory Tract Neoplasms12
Carcinoma11
Thoracic Neoplasms11

Trials

Showing 1 to 25 of 31. Each trial links to its page on Pharma Observatory.

Recently changed trials

Changes observed in the last 7 days, newest first, site-count changes left out. Source: ClinicalTrials.gov.

No changes to these trials in the last 7 days.

Go deeper on Pharma Observatory

Pharma Observatory connects clinical trials, sponsors, sites and investigators in one searchable platform.